ILLINOIS - The University of Illinois Board of Trustees

19781 UNIVERSITY OF ILLINOIS 1 03
On motion of Mr. Livingston, authority was given as recommended.
Recommendations of the University Patent Committee
( 16) The University Patent Committee submits the following recommendations
relating to discoveries and developments by staff members.
I. First Visible Wavelength Direct Nuclear Pumped Laser - M. Alfred Akerman,
formerly research assistant in nuclear engineering, Urbana, George H. Miley,
professor of nuclear engineering and chairperson of Nuclear Engineering Pro-
gram, Urbana, and David A. McArthur, Sandia Laboratories, Albuquerque,
New Mexico, inventors; sponsored by the Department of Energy.
On September 21, 1977, the Board of Trustees transferred its rights in this
concept to the University of Illinois Foundation. On June 14, 1978, University
Patents, Inc., elected not to service the concept under its agreement with the
Foundation because “references appear to preclude generic protection” and “it
doer not appear that we would ever have any hope of recovering our patent ex-
penses.” The Board of Directors of the Foundation on August 3, 1978, returned
the patent rights to the University. It is recommended that the University retain
shop rights and release all other patent rights in this concept to the sponsor, the
Department of Energy.
2. Azaprostaglandin-like Drugs - Duane L. Venton, associate professor of medic-
inal chemistry, Medical Center, Steven Enke, graduate student in medicinal
chemistry, Medical Center, and Guy C. LeBreton, assistant professor of pharma-
cology, Medical Center, inventors.
University Patents, Inc., reported that it wishes to commercialize the invention
which is a drug useful in the storage of blood platelets as well as in the prevention
and/or treatment of occlusive vascular disease. It is recommended that the Uni-
versity transfer its patent rights in the concept to the University of Illinois Founda-
tion.
3. 2-Pro-D-Leu - Roderich Walter, professor of physiology and biophysics and
head of the department, Medical Center, inventor; sponsored by the United
States Department of Health, Education, and Welfare.
University Patents, Inc., reported that it wishes to commercialize this invention
which inhibits tolerance to and physical dependence on morphine. It is recom-
mended that the University transfer its patent rights in this concept to the Uni-
versity of Illinois Foundation, subject to the rights of the sponsor, the United
States Department of Health, Education, and Welfare.
4. SIMPLER System - Thomas T. Chen. assistant professor of clinical science
(medical information science) in the School of Clinical Medicine, Urbana,
Allan H. Levy, professor of clinical science (medical information science) in the
School of Clinical Medicine, Urbana, Douglas Jones, research assistant in the
School of Basic Medical Sciences, Urbana, A. B. Baskin, graduate research as-
sistant in the School of Clinical Medicine, Urbana, and Larry Sherman, for-
merly assistant specialist in automated education in the School of Basic Medical
Sciences, Urbana, inventors.
University Patents, Inc., has agreed to license this development, a computer-
assisted instruction system, and the Modular Computing Corporation wishes to
market it. The University Patent Committee recommends that the University re-
lease its rights in the SIMPLER system software to the University of Illinois
Foundation for marketing.
I concur in these recommendations.
On motion of Mrs. Rader, these recommendations were approved.